Julia Lainster

The management of primary Sjögren’s disease has historically been limited to symptomatic relief, leaving many patients to struggle with systemic complications that extend far beyond the hallmark dry eyes and dry mouth associated with the condition. This chronic autoimmune disorder involves the

The global medical community is currently facing an unprecedented surge in neurodegenerative conditions, creating an urgent demand for diagnostic tools that move beyond traditional qualitative observations. As aging populations increase the prevalence of Alzheimer’s disease and other forms of

Nature has perfected the art of molecular architecture over billions of years, creating viral capsids that serve as the gold standard for structural efficiency and protective capability. These biological shells are composed of hundreds or even thousands of identical protein subunits that

The relentless pursuit of faster, more efficient computing has pushed traditional silicon-based electronics to their physical limits, prompting a shift toward photonic systems that utilize light rather than electrons. While fiber optics have already mastered long-distance data transmission, the

The recent security compromise within the New York City Health and Hospitals system has sent shockwaves through the metropolitan healthcare infrastructure, affecting approximately 1.8 million individuals and exposing a staggering depth of personal data. Investigators confirmed that while the

The pursuit of a definitive solution for treatment-resistant neurological disorders has reached a critical juncture at the University of Miami Miller School of Medicine through its leadership in the BEAT-MS clinical trial. Formally recognized as the ITN077AI study, this Phase 3 multicenter,

The integration of advanced artificial intelligence into the oncological workflow is no longer a distant aspiration but a present-day reality that is fundamentally altering how clinical decisions are made. In the current medical landscape, artificial intelligence serves as a sophisticated digital

Ivan Kairatov stands at the forefront of biopharmaceutical innovation, possessing an intricate understanding of how cutting-edge physics can be harnessed to solve the most pressing mysteries in cellular biology. With a career dedicated to research and development, he has spent years bridging the

The quest for the fountain of youth is shifting away from expensive pharmaceutical interventions toward the quiet, rhythmic discipline of closing one's eyes for exactly seven hours each night. While biohackers once prioritized complex supplement stacks and cryotherapy, a new biological reality has

The realization that Parkinson’s disease is not a monolithic condition but rather a constellation of biological subtypes has fundamentally altered the trajectory of modern clinical research. For over a decade, the Michael J. Fox Foundation has spearheaded a massive observational effort to track how